Abstract:Background: rac-Fenoterol is a beta(2)-adrenoceptor agonist (beta(2)-AR) used in the treatment of asthma. It has two chiral centers and is marketed as a racemic mixture of R,R'- and S,S'-fenoterol (R-F and S-F). Here we report the separation of the R-F and S-F enantiomers and the evaluation of their binding to and activation of the beta(2)-AR. Methods: R-F and S-F were separated from the enantiomeric mixture by chiral chromatography and absolute configuration determined by circular dichroism. beta(2)-AR binding was evaluated using frontal affinity chromatography with a stationary phase containing immobilized membranes from HEK-293 cells that express human beta(2)-AR and standard membrane binding studies using the same membranes. The effect of R-F and S-F on cardiomyocyte contractility was also investigated using freshly isolated adult rat cardiomyocytes. Results: Chiral chromatography of rac-fenoterol yielded separated peaks with an enantioselectivity factor of 1.21. The less retained peak was assigned the absolute configuration of S-F and the more retained peak R-F. Frontal chromatography using membrane-bound beta(2)-AR as the stationary phase and rac-H-3-fenoterol as a marker ligand showed that addition of increasing concentrations of R-F to the mobile phase produced concentration-dependent decreases in rac-H-3-fenoterol retention, while similar addition of S-F produced no change in rac-H-3-fenoterol retention. The calculated dissociation constant of R-F was 472 nM and the number of available binding sites 176 pmol/column, which was consistent with the results from the membrane binding study 460 55 nM (R-F) and 109,000 10,400 nM (S-F). In the cardiomyocytes, RF increased maximum contractile response from (265 +/- 11.6)% to (306 +/- 11.8)% of resting cell length (P < 0.05) and reduced EC50 from -7.0 +/- 0.270 to -7.1 +/- 0.2 log[M] (P < 0.05), while S-F had no significant effect. Discussion: Previous studies have shown that rac fenoterol acts as an apparent beta(2)-AR/Gs selective agonist and fully restores diminished beta(2)-AR contractile response in cardiomyocytes from failing hearts of spontaneously hypertensive rats (SHR). Here we report the separation of the enantiomers of rac-fenoterol and that R-F is the active component of rac-fenoterol. Further evaluation of R-F will determine if it has enhanced selectivity and specificity for beta(2)-AR/GS activation and if it can be used in the treatment of congestive heart failure.

Comparative molecular field analysis of fenoterol derivatives: A platform towards highly selective and effective β2-adrenergic receptor agonists

Comparative Molecular Field Analysis of the Binding of the Stereoisomers of Fenoterol and Fenoterol Derivatives to the Beta2 Adrenergic Receptor.

Design, synthesis and biological evaluations of novel farnesoid X receptor (FXR) agonists

Discovery of a novel series of α-terpineol derivatives as promising anti-asthmatic agents: Their design, synthesis, and biological evaluation.

Effect of fenoterol stereochemistry on the β2 adrenergic receptor system: ligand-directed chiral recognition

Discovery of a Highly Selective β 2 -Adrenoceptor Agonist with a 2-Amino-2-phenylethanol Scaffold as an Oral Antiasthmatic Agent

Effect of Fenoterol Stereochemistry on the Beta 2 Adrenergic Receptor System: Ligand-Directed Chiral Recognition

Enantioselective separation and online affinity chromatographic characterization of R,R- and S,S-fenoterol.

Design, Synthesis, and Biological Evaluation of 4,4’-Difluorobenzhydrol Carbamates as Selective M1 Antagonists

Discovery of Β-Arrestin-biased Β2-Adrenoceptor Agonists from 2-Amino-2-phenylethanol Derivatives

Enantioselective separation and online affinity chromatographic characterization ofR,R- andS,S-fenoterol

Comparative molecular field analysis of gamma-hydroxy butenolide endothelin antagonists

Stereochemistry Of An Agonist Determines Coupling Preference Of Beta(2)-Adrenoceptor To Different G Proteins In Cardiomyocytes

The effect of stereochemistry on the thermodynamic characteristics of the binding of fenoterol stereoisomers to the β2-adrenoceptor

Pharmacophore Modeling of Dual Angiotensin II and Endothelin A Receptor Antagonists.

Discover Natural Compounds As Potential Phosphodiesterase-4B Inhibitors Via Computational Approaches

Discovery and Identification of Novel 5-Hydroxy-4 H -benzo[1,4]oxazin-3-one Derivatives as Potent β 2 -Adrenoceptor Agonists through Structure-Based Design, Synthesis, and Biological Evaluation

β2-adrenergic receptor affinity chromatography with an interaction force analysis model: A method for analysis of active compounds targeting β2-adrenergic receptor

Adenosine A 2A receptor agonists: CoMFA-based selection of the most predictive conformation

Comparative Molecular Field Analysis of γ-Hydroxy Butenolide Endothelin Antagonists

Fenoterol functionally activates the β₃-adrenoceptor in human urinary bladder, comparison with rat and mouse: implications for drug discovery